ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement

July 25, 2013

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

In Brief: Riley Becomes ACCC president; Rep. Green Urges Support Of Cancer Treatment Act

April 9, 1999

U. Arizona Center Finds a Way To Community Rapport

January 18, 1980

House Members Form Group To Address Cancer Policy.

February 23, 2001